Subscribe

Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

ILCPA > Volume 37 > Development and Validation of Rapid LC-MS with...
< Back to Volume

Development and Validation of Rapid LC-MS with Electrospray Ionization for the Quantification of Pramipexole in Human Plasma

Full Text PDF

Abstract:

A rapid, accurate and precise LC-MS method is described for the quantitative determination of pramipexole in human plasma matrix using ropinirole as internal standard. Pramipexole and ropinirole were extracted from plasma by liquid-liquid extraction technique. The method was validated over the concentration range of 100-2514 pg/mL. The method was found to have acceptable accuracy, precision, linearity and selectivity. The mean extraction recovery from spiked plasma samples was in the range of 79.415-87.00 %. The intra-day accuracy of the assay ranged from 98.924 to 112.236 % and intra-day precision ranged from 3.489 to 6.756 %. Inter-day accuracy and precision results for quality control samples ranged between 100.340 and 107.443% of nominal and precision is observed to be 3.970-5.714 %. The pramipexole was found to be stable after several stability studies. The proposed method yielded a quick, simple and reliable protocol for estimating pramipexole concentrations in human plasma.

Info:

Periodical:
International Letters of Chemistry, Physics and Astronomy (Volume 37)
Pages:
1-15
Citation:
P. Lavudu et al., "Development and Validation of Rapid LC-MS with Electrospray Ionization for the Quantification of Pramipexole in Human Plasma", International Letters of Chemistry, Physics and Astronomy, Vol. 37, pp. 1-15, 2014
Online since:
August 2014
Export:
Distribution:
References:

Dooley M., Markham A., Drugs & Aging. 12 (1998) 495-514.

Hoerger T.J., Bala M.V., Rowland C., Greer M., Chrischilles E.A., Holloway R.G., PharmacoEeconomics. 14 (1998) 541-557.

Bennett J.P. Jr., Piercey M.F., J. Neurol. Sci. 163 (1999) 25-31.

Courtney I.J., Jeremy G., Am. Fam. Physician. 75 (2007) 1239-1240.

Inoue Y., Kuroda K., Hirata K., Uchimura N., Kagimura T., Shimizu T., Neuropsychobiology 63 (2011) 35-42.

Lau Y.L., Glenn D.H., Nita I., J. Chromatogr B: Biomed. Sci. Appl. 683 (1996) 217223.

Lau Y.L., Jeffrey M.S., Glenn D.H., Rasmy T., Nita I., J. Chromatogr B: Biomed. Sci. Appl. 683 (1996) 209-216.

Nirogi R.V., Kandikere V., Shrivastava W., Mudigonda K., Maurya S., Ajjala D., Biomed. Chromatogr. 21 (2007) 1151-1158.

Bharathi D.V., Hotha K.K., Sagar P.V., Kumar S.S., Naidu A., Mullangi R., Biomed. Chromatogr. 23 (2009) 212-220.

Uma G., Manimala M., Vasudevan M., Karpagam S., Deecarman., Int. J. Pharma. Sci. Let. 2 (2012) 10-11.

Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), May 2001. ( Received 12 July 2014; accepted 21 July 2014 ).

Show More Hide
Cited By:

[1] D. Mohamed, M. Hegazy, M. Elshahed, S. Toubar, M. Helmy, "Novel contribution to the simultaneous monitoring of pramipexole dihydrochloride monohydrate and levodopa as co-administered drugs in human plasma utilizing UPLC–MS/MS", European Journal of Mass Spectrometry, p. 146906671878880, 2018

DOI: https://doi.org/10.1177/1469066718788800